|
Clonal dynamics of aplastic anemia/paroxysmal nocturnal hemoglobinuria |
Dec 2019 |
Leukemia & Lymphoma |
Aplastic Anemia |
|
Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis |
Dec 2019 |
Leukemia |
Myelodysplastic Syndromes (MDS) |
|
Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party |
Dec 2019 |
Bone Marrow Transplantation |
Aplastic Anemia |
|
Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study |
Dec 2019 |
JAMA Oncology |
Myelodysplastic Syndromes (MDS) |
|
Genetic predisposition to MDS: diagnosis and management |
Dec 2019 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Lowering the boom on lower-risk myelodysplastic syndromes |
Dec 2019 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Monitoring and treatment of MDS in genetically susceptible persons |
Dec 2019 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome |
Dec 2019 |
Hematology. American Society of Hematology. Education Program |
Aplastic Anemia |
|
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes |
Nov 2019 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion |
Oct 2019 |
Annals of Hematology |
Myelodysplastic Syndromes (MDS) |
